Cargando…
Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward
The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer. For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local population-based...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512493/ https://www.ncbi.nlm.nih.gov/pubmed/37735709 http://dx.doi.org/10.1186/s40249-023-01136-6 |